International Biotechnology
data as at: 19/10/2020| Company website | |
| Objective | To achieve capital growth through investing in high growth, development stage biotechnology companies. |
| Management group | SV Health Managers |
| AIC sector | Biotechnology & Healthcare |
| Launch date | 06/05/1994 |
| Financial year end | August |
| Domicile | United Kingdom |
Please note, some investment companies release their Net Asset Values (NAVs) less frequently than daily. For example they may provide NAVs on a weekly, monthly, quarterly or even semi-annual basis. This means that the estimated NAV shown below, and the associated discount/premium to market price, will not necessarily reflect recent market movements.
| Total assets (m) | Price (last close) | Price (bid) | Price (offer) | NAV | Dividend dates | Discount/ premium (%) | Gearing (%) | 5yr dividend growth (%) p.a. | Dividend yield (%) |
|---|---|---|---|---|---|---|---|---|---|
| 317.5 | 818.00 | 814.00 | 822.00 | 807.80 | Jul, Dec | 1.3 | 0 | N/A | 3.0 |
Dividends
Dividends displayed in traded currency.
| Ex-Dividend Date | Dividend amount | Dividend type | Special dividend | Financial year |
|---|---|---|---|---|
| 16/07/2020 | 12.400 | Income | No | 2020 |
| 19/12/2019 | 12.400 | Capital | No | 2020 |
| Dividend cover (years) | Revenue reserves (m) |
|---|---|
| N/A | -38.76 |
Trading information
| ISIN | TIDM | Traded currency |
|---|---|---|
| GB0004559349 | IBT | GBX |
Traded volumes (number of shares)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Total | 199,456 | 2,130,268 | 21,075,670 | 73,255,538 |
| Average | N/A | 107,940 | 83,667 | 57,453 |
Traded values (m)
| Yesterday | 1 month | 1 year | 5 years | |
|---|---|---|---|---|
| Total | 1.63 | 17.41 | 142.08 | 442.21 |
| Average | N/A | 0.88 | 0.57 | 0.35 |
Data provided by Morningstar. Company documents provided by FE fundinfo. 
